Enjoy complimentary customisation on priority with our Enterprise License!
The glycobiology market size is estimated to grow by USD 2.21 billion at a CAGR of 18.52% between 2023 and 2028. The market is experiencing growth driven by several key factors. Firstly, the growing prevalence of cancer is increasing the demand for advanced diagnostic and therapeutic solutions. Secondly, there is a significant increase in expenditure by pharmaceutical companies on research and development (R&D), driving innovation in cancer treatments and other medical fields. Lastly, increasing government and private funding for glycomics and proteomics research is accelerating the discovery of new biomarkers and therapeutic targets, further advancing the field of personalized medicine. These factors collectively underscore the critical role of research and funding in addressing the challenges of cancer and advancing medical science.
There is significant growth across pharmaceutical and biotechnology companies due to the rise in R&D activities such as glycomics & glycobiology and proteomics research. Additionally, there is growing traction for glycobiology in key areas such as (neurobiology, development, and immunology and several applications including biotherapy, antibodies, and the production of heparin analogs). As carbohydrates are bound to glycolipids or glycoproteins, they decide the properties and fate of living cells. One of the main methods for understanding the functional properties of glycoproteins is the purification of targets from recombinant expression systems. Furthermore, there are 76 research/academic institutes, and nearly 145 research labs supporting core proteomic research across India. Hence, such factors are positively impacting the market growth.
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 - 2022, besides analyzing the current market scenario.
To learn more about this report, Request Free Sample
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Agilent Technologies Inc: The company offers glycobiology products such as glycobiology enzymes for N-glycan workflows.
Agilent Technologies Inc., Asparia Glycomics, Bio Techne Corp., Bruker Corp., CD BioGlyco, Chemily Glycoscience, Genovis AB, ICE S.p.a., Lectenz Bio, Ludger Ltd., Merck KGaA, New England Biolabs Inc., NZYTech, Plexera LLC, Shimadzu Corp., Sumitomo Bakelite Co. Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc., Waters Corp., and ZBiotech
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The drug discovery and development segment is estimated to witness significant growth during the forecast period. There is extensive use of glycobiology for drug discovery and development. Glycans are important for several biological processes and they are visible as simple monosaccharides or form more complex structures, including naturally occurring complex carbohydrates in which the sugar moiety is attached to a protein or lipid.
Get a glance at the market contribution of various segments Download PDF Sample
The drug discovery and development segment was the largest segment and was valued at USD 495.40 million in 2018. Carbohydrates play a major role in many biological processes such as acting as the most abundant molecule in the body, an energy source for glucose metabolism, or a structural cell wall component. Complex glycans are needed to fold newly synthesized polypeptides properly and are essential in the final stability, solubility, and transport of the glycoprotein. Additionally, carbohydrates are present on the surface of all cell types, targeting vital biological functions that rely on the specific recognition of glycan structure by other biomolecules. Several advances in mass spectrometry (MS) equipment will allow the mapping of glycan attachment sites, profiling of glycan structural variations, and determining detailed carbohydrate microstructures. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.
Enzymes play a major role in glycobiology. For instance, transferase is a vital component in the complex generation of carbohydrates. In addition, these carbohydrates that are generated are metabolized by glycosidases and altered by a range of other enzymes including sulfatases. Additionally, these enzymes can be utilized as a tool to elucidate the structure and function of carbohydrates. Thus, the rising incidences of drug discovery and development are expected to fuel the growth of this segment, which in turn will drive the market growth during the forecast period.
For more insights about the market share of various regions Download PDF Sample
North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional market growth and trends that will shape the market during the forecast period.
One of the main factors contributing to the significant growth of the global market in North America is the presence of key pharmaceutical and biopharmaceutical companies. Additionally, the regional market is driven by the presence of well-established healthcare infrastructure and accessibility to advanced products. Furthermore, there is an increasing application of glycans for various cancer treatments as well as increasing funding from government organizations to improve the field of glycobiology will fuel the market growth in the region during the forecast period.
The market is witnessing significant growth driven by the development of novel drugs and increased rising analysis spending by pharmaceutical and biotechnology firms. This market focuses on the study of complex carbohydrates and their roles in living things, leveraging technologies like High-Performance Liquid Chromatography and Capillary Electrophoresis (CE). Key areas include lectin inhibitors, polysaccharides, glycosidase inhibitors, and glycosides. The market's expansion is supported by proteomics examination learnings and glycomics research efforts, crucial for understanding disease mechanisms and developing new therapeutics. Corporate expansion and collaboration with administration groups are also prominent trends, enhancing the market's potential and driving innovation within pharmaceutical and biotechnology firms.
One of the key factors driving the market growth is the increase in expenditure by different pharmaceutical companies on R&D. There is increasing investment by several pharmaceutical companies in R&D which include glycomics & glycobiology as well as proteomics research. The average spending of pharmaceutical companies is about 15%-20% of their revenue for R&D purposes. As a result of this R&D spending, it brings several products into the market.
Moreover, it has led to an increase in the demand for pharmaceutical contract packaging. With the adoption of contract packaging, pharmaceutical manufacturers can minimize their capital expenditure and operating cost related to the purchasing of packaging machinery, space for setting up packaging units, and labor costs for the same. Thus, it is positively impacting the market growth. Hence, such factors are expected to drive market growth during the forecast period.
A key factor shaping the market growth is the growing demand for glycomics products for drug discovery and development. Glycans play a vital role in several biological processes. These are important for protein folding and stability and serve as cognitive elements of cell-cell and cell-matrix interactions. Complex glycans play an essential role in the expression of the phenotype of the genotype of the cell and they are mainly present on the surface of cells, deposited in the extracellular matrix, and bound to soluble signaling molecules.
There is an increasing focus on glycans as it has become the center of medically relevant biological processes and is perceived as hotspots for biomedical interventions. Several technological advancements in biophysical technology offer biophysical technology to improve the molecular and structural understanding of these processes and have resulted in the development of effective therapies. Hence, such factors are expected to drive market growth during the forecast period.
The low availability of skilled professionals is one of the key challenges hindering market growth. The drug development process is very risky as well as costly and time-consuming at the same time. Thus it is essential to have well-trained skilled professionals involved in such kinds of experiments and research. Laboratory professionals are essentially skilled and certified professionals who are well-trained in the theoretical and practical aspects of glycobiology.
However, the role of glycobiology professionals spans several areas including staff technologists, research technologists, supervisors, managers, and educators. Several of these professionals lack knowledge about technology and its benefits. As a result, it increases the chances of error or failure in the process. Hence, such factors are expected to hinder market growth during the forecast period.
The market forecast report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market forecasting and growth strategies.
Customer Landscape
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion " for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
Red biotechnology Market: Red biotechnology Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, UK, Germany, China - Size and Forecast
Drug Discovery Informatics Market: Drug Discovery Informatics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, France - Size and Forecast
Pharmaceutical Excipients Market: PharmacAnalysis North America, Europe, APAC, South America, Middle East and Africa - UK, US, Germany, Canada, Japan - Size and Forecast
The market is experiencing rapid growth, driven by advancements in molecular diagnosis, vaccine development, and drug delivery systems. Key components include glycan-binding proteins, glycan antigens, and anti-glycan antibodies, which play crucial roles in understanding glycomes and proteomes. This market addresses chronic diseases like diabetes and obesity, with applications in oncology and antiviral therapeutics.
Innovations in glycan nanostructures and nanomedicine are enhancing biomolecular therapeutics. Support from organizations like the Mizutani Foundation for Glycoscience and increased health-care spending are propelling market growth. The diagnostic industry and proteomics sector are expanding, with pharmaceutical firms and CROs conducting extensive clinical trials. Academic and Research Institutes are pivotal in this field, contributing to global glycomics research.
Market Scope |
|
Report Coverage |
Details |
Page number |
174 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 18.52% |
Market growth 2024-2028 |
USD 2.21 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
15.18 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 41% |
Key countries |
US, Germany, UK, Canada, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Agilent Technologies Inc., Asparia Glycomics, Bio Techne Corp., Bruker Corp., CD BioGlyco, Chemily Glycoscience, Genovis AB, ICE S.p.a., Lectenz Bio, Ludger Ltd., Merck KGaA, New England Biolabs Inc., NZYTech, Plexera LLC, Shimadzu Corp., Sumitomo Bakelite Co. Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc., Waters Corp., and ZBiotech |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for market forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.